Ragulojan Ranjan, Grupke Stephen, Fraser Justin F
UK College of Medicine, University of Kentucky, Lexington, Kentucky.
Department of Neurosurgery, College of Medicine, University of Kentucky, Lexington, Kentucky; Department of Radiology, College of Medicine, University of Kentucky, Lexington, Kentucky.
J Stroke Cerebrovasc Dis. 2019 Mar;28(3):838-844. doi: 10.1016/j.jstrokecerebrovasdis.2018.11.035. Epub 2018 Dec 26.
With rising rates of intravenous drug use, Infectious Intracranial aneurysms (IIAs) are a relevant topic for investigation. We performed a systematic review to better understand current practice patterns and limits of current published literature.
131 publications with a total of 499 patients (665 aneurysms) were included. Of the 499 patients, 83 were single case reports, and 20.5% of the total had multiple aneurysms. 35.8% of all aneurysms were ruptured. Of those reporting treatment, options included conservative antibiotic therapy (30.0%), open surgical intervention (31.1%), and endovascular occlusion (31.8%). Chronologically, publication of IIAs has increased. Usage of endovascular therapies has grown, while conservative and surgical management have declined in the literature. Overall, 56.2% of aneurysms for which conservative therapy was initiated eventually either underwent intervention or death of patient occurred.
The issue of cardiac valve surgery in relationship to aneurysm therapy was discussed in 20.8% (80 patients) of all 384 infectious endocarditis patients; of which 15.0% (12) underwent valve surgery before aneurysm treatment and 85.0 patients (68)% underwent valve surgery after aneurysm treatment. For 51 of the patients where valve surgery followed aneurysm management, the corresponding aneurysm treatment modality could be determined; 58.8% (30) of whom were managed endovascularly. 32.7% (26) of all cases reporting cardiac surgery details underwent cardiac surgery during their admission with the IIA.
Overall, increasing trend of endovascular management of IIAs is evident, and a strong temporal preference exhibited by providers to perform cardiac surgery subsequently to IIA management.
随着静脉注射吸毒率的上升,感染性颅内动脉瘤(IIA)成为一个值得研究的相关课题。我们进行了一项系统综述,以更好地了解当前的实践模式和现有文献的局限性。
纳入131篇出版物,共499例患者(665个动脉瘤)。在499例患者中,83例为单病例报告,20.5%的患者有多个动脉瘤。所有动脉瘤中有35.8%发生破裂。在报告治疗方法的患者中,选择包括保守抗生素治疗(30.0%)、开放手术干预(31.1%)和血管内栓塞(31.8%)。按时间顺序,IIA的出版物数量有所增加。血管内治疗的使用有所增加,而保守治疗和手术治疗在文献中的比例有所下降。总体而言,开始保守治疗的动脉瘤中有56.2%最终接受了干预或患者死亡。
在所有384例感染性心内膜炎患者中,20.8%(80例)讨论了与动脉瘤治疗相关的心脏瓣膜手术问题;其中15.0%(12例)在动脉瘤治疗前接受了瓣膜手术,85.0%(68例)在动脉瘤治疗后接受了瓣膜手术。在51例动脉瘤治疗后进行瓣膜手术的患者中,可以确定相应的动脉瘤治疗方式;其中58.8%(30例)采用血管内治疗。在所有报告心脏手术细节的病例中,32.7%(26例)在因IIA入院期间接受了心脏手术。
总体而言,IIA血管内治疗的增加趋势明显,并且医疗人员在IIA治疗后进行心脏手术表现出强烈的时间偏好。